Basic information

Biomarker: miRNA150-5P

Histology type: endometrial carcinoma

Cohort characteristics

Region: Shatby Alexandria

Followed up time :

Subgroup 1 name : un-intervened endometrial cancer

Subgroup 1 number: 36

Subgroup 2 name: healthy controls

Subgroup 2 number: 36

Cohort statistics: Mean (SD);Range

Total number Group I Group I number Group II Group II number Group III Group III number Group IV Group IV number
72 un-intervened endometrial cancer 36 healthy 36

Sample information

Description: MiRNA150-5P can be suggested as promising biomarkers of endometrial cancer possibly part of a miRNA panel for management.

Sample type : serum

Sample method: RT-qPCR

Expression pattern : circulating overexpression cut off= 1.02

Expression elevation: Relative quantifcation miRNA expression in patients ΔΔCt: is the diference of ΔCt value between the cases and the average of control (ΔΔCt=ΔCt cases – average ΔCt control). The relative quantifcation of miRNA expression was presented as the fold change normalized to the spike in reference mirna 39 and relative to the healthy control samples. Relative quantifcation miRNA expression in healthy control=2–ΔΔCt ΔCt = Ct (target miRNA) − Ct (reference miRNA) ΔΔCt = ΔCt of control − average ΔCt of control

Disease information

Subgroup 1 age: 57.6 ± 8.3

Subgroup 2 age: 53.7±9.4

Related information

Visulization